NDC Active Ingredient Tafenoquine Succinate

Active Ingredient Information

What is the usage for Tafenoquine Succinate?

Tafenoquine is used in combination with another medication (such as chloroquine) to treat and prevent the return of malaria. Malaria is caused by infection with a parasite spread by mosquito bite. After they multiply and grow, the parasites infect your red blood cells and cause symptoms of malaria (such as fever, chills, sweating, headache, other flu-like symptoms). This medication works by stopping the growth of the parasite that causes malaria.

How many products in the NDC database contain Tafenoquine Succinate?

The NDC database has 2 products with the active ingredient Tafenoquine Succinate. The following table lists all the products that have this active ingredient.

NDC Products with Tafenoquine Succinate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0173-0889Proprietary Name: Krintafel Tafenoquine SuccinateTablet, Film CoatedOralGlaxosmithkline LlcACTIVE
69766-079Proprietary Name: Tafenoquine SuccinatePowderMsn Life Sciences Private LimitedACTIVE
<